Clairo

Associate Clinical Data Reviewer

Costa Rica

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Clinical TrialsIndustries

Requirements

Candidates should possess a Bachelor’s degree, which is preferred, and one year of experience in the pharmaceutical industry or other relevant experience is required. Strong problem-solving and organizational skills are necessary, along with demonstrated ability to manage multiple tasks simultaneously and complete work within allocated time frames. Excellent oral and written communication skills, including fluency in English, are also required.

Responsibilities

The Associate Clinical Data Reviewer will ensure the accuracy of client data by conducting manual data review for Clinical Data Management customers, issuing queries based on manual data review requirements, participating in project team meetings, generating metrics and reports, and performing user acceptance testing. They will also adhere to Clinical Data Management processes and standards, read and understand SOPs, and contribute to team efforts by resolving issues and exploring new opportunities. Additionally, they will maintain technical and industry knowledge through training and perform other duties as assigned, while adhering to company policies and SOPs.

Skills

Problem-solving
Organizational skills
Attention to detail
Task management
Communication skills
English fluency

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI